ViroCell, the UK's first clinical trial focused viral vector manufacturer, announces its official launch
ViroCell, the UK’s first clinical trial focused viral vector manufacturer, announces its official launch ViroCell, the UK’s first clinical trial focused viral vector manufacturer, announces its official launch ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today announces its official launch. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as enabling inputs for the manufacture of the rapidly growing Cell and Gene Therapy ...